Effectiveness of Antidepressant Medications for Symptoms of Irritability and Disruptive Behaviors in Children and Adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 26, Issue 8, 2016, Pages 694-704

  Kim, Samuel ^a   Boylan, Khrista ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

antidepressant; children; depression; irritability; treatment; youth

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADOLESCENT; AGGRESSION; AGITATION; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CHILD; CLINICAL TRIAL (TOPIC); COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; CONDUCT DISORDER; DEPRESSION; DISRUPTIVE BEHAVIOR; DROWSINESS; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; EFFECT SIZE; FOLLOW UP; HUMAN; INSOMNIA; IRRITABILITY; MANIA; MENTAL DISEASE; OBSESSIVE DIFFICULT TEMPERAMENT; OPPOSITIONAL DEFIANT DISORDER; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SIDE EFFECT; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; UPPER ABDOMINAL PAIN; DRUG EFFECTS; PROBLEM BEHAVIOR; TREATMENT OUTCOME;

ADOLESCENT; AGGRESSION; ANTIDEPRESSIVE AGENTS; CHILD; HUMANS; IRRITABLE MOOD; PROBLEM BEHAVIOR; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84991730043     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2015.0127     Document Type: Article

References (32)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Revised. Washington, DC: American Psychiatric Association; 1987.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Armenteros JL, Lewis JE: Citalopram treatment for impulsive aggression in children and adolescents: An open pilot study. J Am Acad Child Adolesc Psychiatry 41:522-529, 2002.
4. Axelson D, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA, Horwitz SM, Arnold LE, Frazier TW, Ryan N, Demeter C, Gill MK, Hauser-Harrington JC, Depew J, Kennedy SM, Gron BA, Rowles BM, Birmaher B: Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the longitudinal assessment of manic symptoms study. J Clin Psychiatry 73:1342-1350, 2012.
5. Blader JC: Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior. J Clin Psychopharmacol 26:419-425, 2006.
6. Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, Debar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression. JAMA 299:901-913, 2008.
7. Carlson GA, Rapport MD, Kelly KL, Pataki CS: Methylphenidate and desipramine in hospitalized children with comorbid behavior and mood disorders: Separate and combined effects on behavior and mood. J Child Adolesc Psychopharmacol 5:191-204, 1995.
8. Carlson GA, Glovinsky I: The concept of bipolar disorder in children. A history of the bipolar controversy. Child and Adolescent Psychiatric Clinics of North America, 18:257-271, 2009.
9. Constantino JN, Liberman M, Kincaid M: Effects of serotonin re-uptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: Results of an open trial. J Child Adolesc Psychopharmacol 7:31-44, 1997.
10. Copeland WE, Angold A, Costello EJ, Egger H: Prevalence, co-morbidity, and correlates of DSM-5 disruptive mood dysregulation disorder. Am J Psychiatry 170:173-179, 2013.
11. Dickstein D, Leibenluft EL: Beyond dogma: From diagnostic controversies to data about pediatric bipolar disorder and children with chronic irritability and mood. Israel J Psychiatry 49:52-61, 2012.
12. Dougherty LR, Smith VC, Bufferd SJ, Carlso, GA, Stringaris A, Leibenluft E, Klein DN: DSM-5 disruptive mood dysregulation disorder: Correlates and predictors in young children. Psychol Med 21:1-12, 2014.
13. Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J: Treatment of adolescents with depression study (TADS): Safety results. J Am Acad Child Adolesc Psychiatry 45:1440-1455, 2006.
14. Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC: The importance of irritability as a symptom of major depressive disorder: Results from the National Comorbidity Survey Replication. Mol Psychiatry 15:856-867, 2009.
15. Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR Jr, Bangalore SS, Butter EM, Buchan-Page KA, Hurt EA, Austin AB, Grondhuis SN, Aman MG: Risperidone added to parent training and stimulant medication: Effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. J Am Acad Child Adolesc Psychiatry 53:948-959, 2014.
16. Garland EJ, Weiss M: Case study: Obsessive difficult temperament and its response to serotonergic medication. J Am Acad Child Adolesc Psychiatry 35:916-920, 1996.
17. Gorman DA, Gardner DM, Murphy AL, Feldman M, Belanger SA, Steele MM, Boylan K, Cochrane-Brink K, Goldade R, Soper PR, Ustina J, Pringsheim T: Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry 60:62-76, 2015.
18. Holtmann M, Buchmann AR, Esser G, Schmidt MH, Banaschewski T, Laught M: The child behavior checklist-dysregulation impairment: A longitudinal analysis. J Child Psychol Psychiatry 52:139-147, 2010.
19. Hilton RC, Rengasamy M, Mansoor B, He J, Mayes T, Emslie GJ, Porta G, Clarke GN, Wagner KD, Birmaher B, Keller MB, Ryan N, Shamseddeen W, Asarnow JR, Brent DA: Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression. J Am Acad Child Adolesc Psychiatry 52:482-492, 2013.
20. Jacobs RH, Becker-Weidman EG, Reinecke MA, Jordan N, Silva SG, Rohde P, March JS: Treating depression and oppositional behavior in adolescents. J Clin Child Adolesc Psychol 39:559-567, 2010.
21. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Ryan N: Schedule for affective disorders and schizophrenia for school-age children-Present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988, 2001.
22. Kay SR, Wolkenfield F, Murrill LM: Profiles of aggression among psychiatric patients: II. Covariates and predictors. J Nerv Ment Dis 176:547-557, 1988.
23. Krieger FV, Leibenluft E, Stringaris A, Polanczyk V: Irritability in children and adolescents: Past concepts, current debates, and future opportunities. Rev Bras Psiquiatr 35:S32-S39, 2013.
24. Krieger FV, Pheula GF, Coelho R, Zeni T, Tramontina S, Zeni CP, Rohde LA: An open-label trial of risperidone in children and adolescents with severe mood dysregulation. J Child Adolesc Psy-chopharmacol 21:237-243, 2011.
25. Kuny AV, Althoff RR, Copeland W, Bartels M, Van Beijsterveldt CE, Baer J, Hudziak JJ: Separating the domains of oppositional behaviour: Comparing latent models of the Conners' Oppositional Subscale. J Am Acad Child Adolesc Psychiatry 52:172-183, 2013.
26. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S: Fluoxetine, cognitive-behavioral therapy and their combination for adolescents with depression. JAMA 292: 807-820, 2004.
27. Nevels RM, Dehon EE, Alexander K, Gontkovsky ST: Psycho-pharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options. Exp Clin Psychopharmacol 18:184-201, 2010.
28. Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ: A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:193-204, 2000.
29. Roy AK, Lopes V, Klein RG: Disruptive mood dysregulation disorder: A new diagnostic approach to chronic irritability in youth. Am J Psychiatry 171:918-924, 2014.
30. Stringaris A, Goodman R, Fernandino S, Rizdon V, Muhrer E, Lei-benluft E, Brotman MA: Affective Reactivity Index: A concise irritability scale for clinical and research settings. J Child Psychol Psychiatry 53:1109-1117, 2012.
31. Stringaris A, Maughan B, Copeland W, Costello EJ, Angold A: Irritable mood as a symptom of depression in youth: Prevalence, developmental, and clinical correlates in the Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry 52:831-840, 2013.
32. Zubieta JK, Alessi NE: Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children. J Clin Psychopharmacol 12:346-351, 1992.